Shockwave Medical Enrolls First Patient in FORWARD CAD Pivotal Study of Novel Forward Intravascular Lithotripsy Platform
April 08, 2025
April 08, 2025
NEW BRUNSWICK, New Jersey, April 8 -- Shockwave Medical, Inc., a subsidiary of Johnson and Johnson, issued the following news release:
* * *
Shockwave Medical Enrolls First Patient in FORWARD CAD Pivotal Study of Novel Forward Intravascular Lithotripsy Platform
Investigational Device Exemption (IDE) study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter in difficult-to-cross, calcified coronary lesions
SAN . . .
* * *
Shockwave Medical Enrolls First Patient in FORWARD CAD Pivotal Study of Novel Forward Intravascular Lithotripsy Platform
Investigational Device Exemption (IDE) study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter in difficult-to-cross, calcified coronary lesions
SAN . . .